LGALS7 抗体 (AA 55-104)
Quick Overview for LGALS7 抗体 (AA 55-104) (ABIN6749119)
抗原
See all LGALS7 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 55-104
-
特异性
- Human LGALS7 / Galectin-7
-
预测反应
- Percent identity by BLAST analysis: Mouse (85%) Dog, Pig (84%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa55-104 of human LGALS7 (P47929, NP_002298). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset (100%), Mouse (85%), Dog, Horse, Pig (84%), Rat (78%).
Type of Immunogen: Synthetic peptide
-
-
anti-Galectin 7 (LGALS7) (AA 1-136) antibody
LGALS7 适用: 人 WB 宿主: 小鼠 Monoclonal C2 unconjugated
anti-Galectin 7 (LGALS7) (AA 31-100) antibodyLGALS7 适用: 大鼠 WB, ELISA, ICC, IF (cc), IF (p), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Galectin 7 (LGALS7) (AA 1-136) antibodyLGALS7 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Galectin 7 (LGALS7) antibodyLGALS7 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Galectin 7 (LGALS7) (AA 1-136) antibodyLGALS7 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 6B5 unconjugated
anti-Galectin 7 (LGALS7) (AA 1-128) antibodyLGALS7 适用: 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Galectin 7 (LGALS7) (AA 2-136) antibodyLGALS7 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Galectin 7 (LGALS7) antibody (FITC)LGALS7 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal FITC
anti-Galectin 7 (LGALS7) antibody (HRP)LGALS7 适用: 人 WB, ELISA, IHC, IHC (p) 宿主: 兔 Polyclonal HRP
anti-Galectin 7 (LGALS7) (AA 2-136) antibodyLGALS7 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
